BN83495 in Prostate Cancer
- 09 October 2024 - 1 mins read
The purpose of the study is to evaluate the pharmacodynamic profile and safety of BN83495 in patients with prostate cancer with disease progression while on androgen ablative therapy
09 October 2024
1 mins read
Which is the Best Dose of Dysport in Helping With Hip Pain for Children With Cerebral Palsy?
09 October 2024
1 mins read
Study to Assess Impact of Dysport Injections Early After Stroke on Upper Limb Spasticity Progression
09 October 2024
1 mins read
Efficacy and Safety Study of Botulinum Toxin Type-A (Dysport®) in Continent Female Subjects Suffering From Idiopathic Overactive Bladder
09 October 2024
1 mins read
Dysport® Pediatric Lower Limb Spasticity Follow-on Study
09 October 2024
1 mins read
Dysport® Adult Lower Limb Spasticity Follow-on Study
09 October 2024
1 mins read
Dysport® Pediatric Lower Limb Spasticity Study
09 October 2024
1 mins read
Dysport® Adult Lower Limb Spasticity Study
09 October 2024
1 mins read
Efficacy and Safety of Botulinum Toxin Type A Haemagglutinin Complex Next Generation (BTX-A-HAC NG) in Glabellar Lines
09 October 2024
1 mins read
Efficacy and Safety of Clostridium Botulinum Toxin Type A to Improve Appearance of Moderate to Severe Glabellar Lines
09 October 2024
1 mins read